A phase II trial of high-dose gemcitabine (GEM) plus cisplatin (CDDP) in advanced non small cell lung cancer(NSCLC).: Preliminary results.

被引：0
|
作者：
Isla, D [1 ]
Mayordom, JI [1 ]
Yubero, A [1 ]
Cajal, R [1 ]
Bueso, P [1 ]
Herráez, J [1 ]
Martí, JL [1 ]
Murillo, L [1 ]
Sáenz, A [1 ]
Escudero, P [1 ]
García-Prats, MD [1 ]
Tres, A [1 ]
机构：
[1] Univ Zaragoza, Div Med Oncol, Clin Hosp, Zaragoza, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [41] Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Burkes, RL
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    Schulz, M
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 48 - 54
  • [42] Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
    Xiong, Jian Ping
    Feng, Miao
    Qiu, Feng
    Xu, Jun
    Tao, Qing Song
    Zhang, Ling
    Xiang, Xiao Jun
    Zhong, Lu Xing
    Yu, Feng
    Ma, Xu Tian
    Gong, Wang Yong
    LUNG CANCER, 2008, 60 (02) : 208 - 214
  • [43] A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting
    Hussain, S. A.
    Palmer, D. H.
    Swinson, D. E.
    Riley, P.
    Wills, A.
    Brown, C.
    Draycott, C.
    El-Modir, A.
    Peake, D. R.
    Rea, D. W.
    Chetiyawardana, A. D.
    Cullen, M. H.
    ONCOLOGY REPORTS, 2008, 20 (01) : 233 - 237
  • [44] Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial
    Georgoulias, V
    Papadakis, E
    Alexopoulos, A
    Stavrinidis, E
    Bania, E
    Rapti, A
    Grigoratou, T
    Kouroussis, C
    Kakolyris, S
    Samonis, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S249 - S249
  • [45] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Garassino, I
    Campagnoli, E.
    Cavina, R.
    Soto, Parra H. J.
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI20 - XI20
  • [46] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
  • [47] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Campagnoli, E.
    Garassino, I.
    Cavina, R.
    Parra, H. J. Soto
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    LUNG CANCER, 2006, 52 : S20 - S20
  • [49] Lipoplatin plus gemcitabine versus cisplatin plus gemcitabine in NSCLC: Preliminary results of a phase III trial
    Boulikas, T.
    Mylonakis, N.
    Sarikos, G.
    Angel, J.
    Athanasiou, A.
    Politis, G.
    Rapti, A.
    Rassidakis, A.
    Karabatzaki, M.
    Anyfantis, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Campagnoli, E.
    Garassino, I.
    Cavina, R.
    Parra, H. J. Soto
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    PROCEEDINGS OF THE 10TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2006, : 29 - +
12345